Early in the COVID-19 pandemic, many African leaders implemented prevention measures such as lockdowns, travel bans, border closures, and school closures. While these efforts may have helped slow the spread of the virus on ...
Jun 23, 2021
0
0
Two recent studies led by researchers from the University of Minnesota Medical School add new evidence to the impact of how drug price increases affect U.S. patients and the overall cost of health care.
Jun 18, 2021
1
3
Federal agencies that regulate drug pricing and healthcare insurance are concerned that an industry practice of using rebates to lower drug costs for insurers has led to increases in list prices and out-of-pockets costs for ...
Jun 15, 2021
0
4
Hospital price transparency is intended to help inform patients about the cost of services and procedures before they receive them. Since Jan. 1, 2021, hospitals in the U.S. have been required by The Centers for Medicare ...
Jun 4, 2021
0
2
A new West Health/Gallup survey finds nearly all Democrats (97%) and the majority of Republicans (61%) support empowering the federal government to negotiate lower prices of brand-name prescription drugs covered by Medicare. ...
Jun 3, 2021
0
1
As Congress considers legislation to reform prescription drug pricing, a new analysis conducted by the West Health Policy Center and released by its Council for Informed Drug Spending Analysis (CIDSA) estimates that the Elijah ...
May 20, 2021
0
3
(HealthDay)—U.S. hospitals have been required to make their prices public since 2019, but 18 months into the rule more than half weren't doing it, a new study finds.
May 18, 2021
0
2
When drug manufacturers raise the list price for brand-name prescription drugs, do patients' out-of-pocket costs rise too? A new study published in JAMA Network Open by Dr. Benjamin Rome and colleagues in the Brigham's Division ...
May 4, 2021
0
0
Israel signed Monday an agreement with pharmaceutical giant Pfizer enabling the Jewish state to obtain millions more doses of vaccines, a government statement said.
Apr 19, 2021
0
2
The head of Pfizer said in an interview aired Thursday that people will "likely" need a third dose of his company's COVID-19 shot within six to 12 months of vaccination, while elsewhere defending the relatively higher cost ...
Apr 16, 2021
0
80
